Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance
Phibro Animal Health reported Q3 net sales of $383.5 million, up 10% year-over-year, driven by a 13% increase in its Animal Health segment. Adjusted EBITDA rose 11% to $60.8 million, while net income increased 15% to $24.0 million.
Key figures
- Eps
- 0.59
- Revenue
- 383500000
- Guidance
- FY26 Net sales $1.46B-$1.50B, Adjusted EBITDA $247M-$255M
- Revenue Yoy
- 10%
- Fcf
- 12800000
- Adjusted eps
- 0.76
- Adjusted ebitda
- 60800000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.